Antengene Biologics Limited
5 clinical trials · Sponsor
◉ Watch Antengene Biologics Limited
| Record | Firm | Date |
|---|---|---|
| A Study of ATG-201 in Adult Participants With Autoimmune Diseases (NCT07732309) | Antengene Biologics Limited | 2026-09-01 |
| A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-positive, HER2-negative, Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaUnresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (NCT07327229) | Antengene Biologics Limited | 2026-02-27 |
| A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas (NCT06028373) | Antengene Biologics Limited | 2023-12-08 |
| A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors (NCT05718895) | Antengene Biologics Limited | 2023-03-27 |
| A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas (NCT04986865) | Antengene Biologics Limited | 2021-12-15 |
Track Antengene Biologics Limited automatically
Every clearance here is in the API, with alerts when new ones post.